Neuromod Labs
Science-Led. Survivor-Proven.
Reclaim clarity and vitality with advanced, evidence-based treatments for neuropathy, pain and cognitive, emotional and relational health.
What Do We Do?
-
We use our expertise in non-drug, non-invasive treatment methods for a range of pain, cognitive health and mental health problems. While cancer survivorship is has been the core of our research mission, we bring our combination of cutting-edge neuroscience and psychotherapy to help anyone restore well-being.
-
Personalized evaluation is fundamental to our approach, based on our experience of quantitatively measuring individual responses during research and decades of private practice in Family Therapy.
-
We have a specialty in treating CIPN and cancer-related conditions, based on our research at MDA Anderson Cancer center.
-
Aside from providing clinical services, we want to improve access to treatment, continue to evolve research and implement research findings widely and quickly. We do this through a charitable foundation, business partnerships, and a focus on training and education.
What Methods Do We Use?
Our team has deep expertise is several non-invasive treatments. Our approach, developed from our research background, is strictly to apply these techniques only where there is solid scientifically proven basis. We can tailor all the applications to your case and integrate into your ongoing care.
Meet Dr Sarah Prinsloo
Dr. Sarah Prinsloo is an applied neuroscientist who enjoyed a 15 year career as a faculty member at The University of Texas MD Anderson Cancer Center in Houston Texas. Her research focuses on neuromodulation, pain and cancer-related symptom management.
Dr. Prinsloo is a Board member of BCIA, the organization that sets standards and certification of Neurofeedback practitioners. She also has a twenty-plus year career as a Licensed Marriage and Family therapist.
In her research, she measured different patient responses to neuromodulatory treatments. In her private practice she experienced the broad range of environmental and relational factors that influence mental health. These deep experiences of the uniqueness of patients drive her approach providing care:
-
Establish a comprehensive understanding of all the factors that brought you where you are.
-
Develop a holistic, highly personalized evaluation of your symptoms to restore wellness and balance.
-
Provide awareness, education and strategies to help you sustain and manage your personal wellness in the future.
She is also on a mission to accelerate implementation of her research work and bring the latest non-pharmaceutical therapies to cancer survivors.
What Should You Expect?
1. Free consultation
2. Assessment
3. Personalized Therapy
4. Ongoing Support
Led by clinicians and researchers, we explain everything in plain language and guide you step by step. Our team studied over 550 survivors at a major cancer center in Houston—and now brings that knowledge directly to you. --Neuromod Labs Team
Why Was Neuromod Labs Founded?
Advances in neuroscience are moving faster than ever, discovering new ways to ease the symptoms that affect millions of people living with the effects of cancer and other medical conditions. My lab was the first in the nation to bring neuromodulation technology to cancer survivorship. We have discovered neuromodulation therapies that show clear benefits for cancer survivors—reducing neuropathy, pain, fatigue, cognitive fog, and other treatment‑related symptoms.
However, scientific progress alone is not enough. Despite strong evidence supporting these therapies, most patients wait years—sometimes decades—before they become part of routine care. This delay is especially challenging for cancer survivors, who frequently live with persistent symptoms long after treatment ends.
Our Initiative was created to change that timeline. We bring together scientific discovery, clinical innovation, and real‑world implementation to ensure that proven neuromodulation therapies reach the individuals, families, and communities who need them most.
Content reviewed by: Dr Sarah Prinsloo, PhD
Last Updated: July 2026